The Gly-X brand, founded in 2000 (United States), from 274 sister brands and 2617 competing brands. Gly-X is a brand of Agilent Technologies, Inc., listed on the stock exchange of New York. Gly-X belongs to the Medical Diagnostics & Research business sector.